First the ‘market’ has to be created before it can be exploited. As far as I’m aware there wasn’t a (big enough) market for weight loss drugs 40 years ago?
Big Ag and Big Chemical and Big Mac needed time to poison the population with sugar, seed oils and factory food. Create the patients and have them beg for a cure.
What is surprising about Pfizer dropping the ball with GLP-1 is around the same time they noticed an interesting side effect of a cardiovascular drug and decided to sell the side effect instead (Viagra). So even people good at one thing may miss other opportunities right in front of them.
One still-underappreciated consequence of the Ozempic boom is its impact on the protein market. People taking Ozempic are often advised to increase their protein intake to help preserve muscle mass during weight loss.
I hadn't known until reading this that Ozempic "slows down gastric emptying". That sounds kind of worrisome, at least going on the theory that we want food to go through us at a reasonable pace. But I'll say this, my brother-in-law, who was in terrible health, has lost 100 lbs on Ozempic and is in much better shape overall on the stuff. Will be interesting to see how Ozempic stands the test of time, sometimes medicines, like aspirin, really are magic bullets.
So the product is in the public domain? I know Lilly has, surprisingly, allowed market forces to work, and has recognized that lower prices lead to more demand and more profit, why aren’t compounded versions $10 a dose? And Novo Nordisk in the dumpster? They should be en fuego….
Pfizer wanted obese people which in turn churn out more money from other treatments that unhealthy people need. Not that ozempic doesn’t have its share of side effects but obesity can generate more income than curing it. And I think they were seeing this as a headwind to there bottom line at the time. We all know big pharma loves sick, depressed, zombied out patients. Prescriptions = subscriptions lol
Actually, they didn't realize the potential of GLP-1 to treat obesity in type II diabetes. The latter is a very obvious problem that was well-known by the 1990s.
First the ‘market’ has to be created before it can be exploited. As far as I’m aware there wasn’t a (big enough) market for weight loss drugs 40 years ago?
Big Ag and Big Chemical and Big Mac needed time to poison the population with sugar, seed oils and factory food. Create the patients and have them beg for a cure.
What a sick culture.
They had to create their patients first.
What is surprising about Pfizer dropping the ball with GLP-1 is around the same time they noticed an interesting side effect of a cardiovascular drug and decided to sell the side effect instead (Viagra). So even people good at one thing may miss other opportunities right in front of them.
Serendipity all the way down.
And in 20 years there will be commercials on TV like the Camp Lejeune ones for Ozempic users.
One still-underappreciated consequence of the Ozempic boom is its impact on the protein market. People taking Ozempic are often advised to increase their protein intake to help preserve muscle mass during weight loss.
I can write a book about new products that wound up in limbo and then rediscovered.
Wait for the movie.
A decade from now the world will probably learn that the long term side effects are brutal.
Zantac and Belviq (weight loss drug 2012-2020, pulled due to cancer risk) are just two that immediately come to mind. There are dozens of others.
I hadn't known until reading this that Ozempic "slows down gastric emptying". That sounds kind of worrisome, at least going on the theory that we want food to go through us at a reasonable pace. But I'll say this, my brother-in-law, who was in terrible health, has lost 100 lbs on Ozempic and is in much better shape overall on the stuff. Will be interesting to see how Ozempic stands the test of time, sometimes medicines, like aspirin, really are magic bullets.
One in eight adults is taking it? I see no evidence for that. People are as fat as ever.
So the product is in the public domain? I know Lilly has, surprisingly, allowed market forces to work, and has recognized that lower prices lead to more demand and more profit, why aren’t compounded versions $10 a dose? And Novo Nordisk in the dumpster? They should be en fuego….
Pfizer wanted obese people which in turn churn out more money from other treatments that unhealthy people need. Not that ozempic doesn’t have its share of side effects but obesity can generate more income than curing it. And I think they were seeing this as a headwind to there bottom line at the time. We all know big pharma loves sick, depressed, zombied out patients. Prescriptions = subscriptions lol
Actually, they didn't realize the potential of GLP-1 to treat obesity in type II diabetes. The latter is a very obvious problem that was well-known by the 1990s.
No, what matters most is funky and misaligned marketing.